Visualization of bone pathologies and lung cancer with 99mTc-glucose phosphate: a comparative study.
Glucose phosphate (GP) labelled with 99mTc was used to obtain scintigraphic images of bone lesions in one group of patients (n = 28) and of lung tumors in another (n = 35). All bone lesions detected by 99mTc-MDP were also demonstrated by 99mTc-GP; all lung tumors except 4 were detected by 99mTc-GP, the failure rate being about the same as that for 67Ga. The use of 99mTc-GP is preferable to that of 99mTc-MDP because the former does not accumulate in normal bone; the advantage of 99mTc-GP over 67Ga lies in its better physical characteristics and in the fact that the result of the study is available within a few hours rather than three days.
Caner
B E
BE
Department of Nuclear Medicine, Hacettepe University Medical Faculty, Ankara, Turkey.
Ercan
M T
MT
Bekdik
C F
CF
Varoğlu
E
E
Müezzinoğlu
S
S
Duman
Y
Y
Erbengi
G F
GF
D000293:Adolescent; D000328:Adult; D000368:Aged; D001845:Bone Cysts / Q000175:diagnosis; D001847:Bone Diseases / Q000000981:diagnostic imaging*; D001859:Bone Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary; D002648:Child; D002675:Child, Preschool; D005260:Female; D005958:Glucosephosphates; D006801:Humans; D006961:Hyperparathyroidism / Q000000981:diagnostic imaging; D008175:Lung Neoplasms / Q000000981:diagnostic imaging*; D008297:Male; D008875:Middle Aged; D015609:Organotechnetium Compounds; D010001:Osteitis Deformans / Q000000981:diagnostic imaging; D011471:Prostatic Neoplasms / Q000473:pathology; D011877:Radionuclide Imaging; D013669:Technetium Tc 99m Medronate
D005958:Glucosephosphates; D015609:Organotechnetium Compounds; C072896:technetium Tc 99m glucose-1-phosphate; D013669:Technetium Tc 99m Medronate